Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2026-01-21 @ 11:44 PM
Study NCT ID:
NCT03493568
Status:
TERMINATED
Last Update Posted:
2024-02-09
First Post:
2018-03-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)
Sponsor:
IRCCS San Raffaele
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Be-OnE Study
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |